Ortin Global Limited (BOM:539287)

India flag India · Delayed Price · Currency is INR
13.75
-0.65 (-4.51%)
At close: May 13, 2026
Market Cap111.81M -15.2%
Revenue (ttm)1.12M -79.6%
Net Income-8.95M
EPS-1.10
Shares Out 8.13M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,757
Open15.12
Previous Close14.40
Day's Range13.69 - 15.12
52-Week Range10.56 - 19.15
Beta0.52
Analystsn/a
Price Targetn/a
Earnings DateMay 30, 2026

About Ortin Global

Ortin Global Limited engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders; formulations, such as anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helmenthetics, analgesics and antipyretics, anti-biotics-quinolones, anti-biotic-pencillins, antifungal, cephalosporins, and macrolides. Its formulations also include chemo therapeutics, antacids and anti-ulceran... [Read more]

Industry Pharmaceutical Preparations
Founded 1986
Employees 3
Stock Exchange Bombay Stock Exchange
Ticker Symbol 539287
Full Company Profile

Financial Performance

In fiscal year 2025, Ortin Global's revenue was 3.43 million, a decrease of -84.61% compared to the previous year's 22.26 million. Losses were -8.46 million, -89.47% less than in 2024.

Financial Statements